Danielle Epstein LICSW

Epizyme is a global biopharmaceutical leader focused on developing innovative medicines in oncology, neuroscience, and rare diseases to enhance the quality of life for individuals worldwide. The company is dedicated to advancing research and creating impactful treatments that address unmet medical needs in various therapeutic areas, striving to make a positive difference in the lives of patients and their families. Generated from their website's infomation

Epizyme is a global biopharmaceutical company based in Cambridge, MA, dedicated to improving patients' lives through research, innovation, and the development of transformative medicines in Oncology, Rare Disease, and Neuroscience. With a focus on areas of high unmet medical need, Epizyme is accelerating its momentum and rapidly expanding its pipeline to bring the full potential of its innovative medicines to patients. Guided by patient outcomes and supported by a culture of collaboration and excellence, Epizyme leverages its global reach and R&D firepower to partner with like-minded innovators and develop the next generation of medicines. With a strong track record in commercializing its medicines and a commitment to making a real impact for people living with high unmet medical needs, Epizyme is a leader in its field, leveraging its infrastructure, innovation, and passion to develop new therapies and valuable collaborations.Generated from the website

Cugene Corp is a clinical-stage biotechnology company based in Waltham, MA, specializing in the development of precision immunology and oncology medicines. Their innovative approach involves leveraging specific immune cells to treat autoimmune diseases and cancer, using precision molecular engineering and molecular modeling to create novel molecules with highly selective immune stimulatory capacities. With a focus on efficacy, safety, and synergy, Cugene designs molecules with superior pharmacokinetics, target cell specificity, and tumor-killing capabilities, while minimizing unwanted side effects. Their cutting-edge biotech advancements aim to address unmet medical needs in autoimmune disease and oncology, attracting top talent through a collaborative culture and offering benefits such as medical, dental, vision, and work-life balance.Generated from the website